Department of Medical Microbiology;
Weifang Medical University;
Weifang 261053;
Shandong;
China;
National Institute for Viral Diseases Control and Prevention;
China Center for Disease Control and Prevention;
Beijing 102206;
China;
School of Clinical Medicine;
Weifang Medical University;
Weifang 261053;
Shandong;
China;
Morphological Laboratory;
Weifang Medical University;
Weifang 261053;
Shandong;
China;
Human cytomegalovirus; Coronary heart disease; Antibody; CD14+CD16+monocytes; Weifang;